Cargando…
Moving forward with forward genetics: A summary of the INFRAFRONTIER Forward Genetics Panel Discussion
In the last few decades, forward genetics approaches have been extensively used to identify gene function. Essentially, forward genetics is the elucidation of the genetic basis of a specific phenotype by screening a population containing random genomic modifications that alter gene function. These a...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
F1000 Research Limited
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8634052/ https://www.ncbi.nlm.nih.gov/pubmed/34900227 http://dx.doi.org/10.12688/f1000research.25369.1 |
_version_ | 1784608058019676160 |
---|---|
author | Ali Khan, Asrar Raess, Michael de Angelis, Martin Hrabe |
author_facet | Ali Khan, Asrar Raess, Michael de Angelis, Martin Hrabe |
author_sort | Ali Khan, Asrar |
collection | PubMed |
description | In the last few decades, forward genetics approaches have been extensively used to identify gene function. Essentially, forward genetics is the elucidation of the genetic basis of a specific phenotype by screening a population containing random genomic modifications that alter gene function. These approaches have shed light on some essential gene functions in development and disease and have expanded the realm of understanding for genetic disorders. Due to the availability of efficient mutagenesis methods, phenotyping techniques, reliable validation, comprehensive sequence information and translational potential, mouse models are favored for forward genetics approaches. However, in this post-genomic CRISPR-Cas9 era, the relevance and future of forward genetics was brought into question. With more than 7300 mouse strains archived and close interactions with several leading mouse researchers around the world, INFRAFRONTIER - the European Research Infrastructure for mouse models organised a panel discussion on forward genetics at the International Mammalian Genome Conference 2018 to discuss the future of forward genetics as well as challenges faced by researchers using this approach in the current research environment. The commentary presents an overview of this discussion. |
format | Online Article Text |
id | pubmed-8634052 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | F1000 Research Limited |
record_format | MEDLINE/PubMed |
spelling | pubmed-86340522021-12-09 Moving forward with forward genetics: A summary of the INFRAFRONTIER Forward Genetics Panel Discussion Ali Khan, Asrar Raess, Michael de Angelis, Martin Hrabe F1000Res Opinion Article In the last few decades, forward genetics approaches have been extensively used to identify gene function. Essentially, forward genetics is the elucidation of the genetic basis of a specific phenotype by screening a population containing random genomic modifications that alter gene function. These approaches have shed light on some essential gene functions in development and disease and have expanded the realm of understanding for genetic disorders. Due to the availability of efficient mutagenesis methods, phenotyping techniques, reliable validation, comprehensive sequence information and translational potential, mouse models are favored for forward genetics approaches. However, in this post-genomic CRISPR-Cas9 era, the relevance and future of forward genetics was brought into question. With more than 7300 mouse strains archived and close interactions with several leading mouse researchers around the world, INFRAFRONTIER - the European Research Infrastructure for mouse models organised a panel discussion on forward genetics at the International Mammalian Genome Conference 2018 to discuss the future of forward genetics as well as challenges faced by researchers using this approach in the current research environment. The commentary presents an overview of this discussion. F1000 Research Limited 2021-06-08 /pmc/articles/PMC8634052/ /pubmed/34900227 http://dx.doi.org/10.12688/f1000research.25369.1 Text en Copyright: © 2021 Ali Khan A et al. https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the terms of the Creative Commons Attribution Licence, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Opinion Article Ali Khan, Asrar Raess, Michael de Angelis, Martin Hrabe Moving forward with forward genetics: A summary of the INFRAFRONTIER Forward Genetics Panel Discussion |
title | Moving forward with forward genetics: A summary of the INFRAFRONTIER Forward Genetics Panel Discussion |
title_full | Moving forward with forward genetics: A summary of the INFRAFRONTIER Forward Genetics Panel Discussion |
title_fullStr | Moving forward with forward genetics: A summary of the INFRAFRONTIER Forward Genetics Panel Discussion |
title_full_unstemmed | Moving forward with forward genetics: A summary of the INFRAFRONTIER Forward Genetics Panel Discussion |
title_short | Moving forward with forward genetics: A summary of the INFRAFRONTIER Forward Genetics Panel Discussion |
title_sort | moving forward with forward genetics: a summary of the infrafrontier forward genetics panel discussion |
topic | Opinion Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8634052/ https://www.ncbi.nlm.nih.gov/pubmed/34900227 http://dx.doi.org/10.12688/f1000research.25369.1 |
work_keys_str_mv | AT alikhanasrar movingforwardwithforwardgeneticsasummaryoftheinfrafrontierforwardgeneticspaneldiscussion AT raessmichael movingforwardwithforwardgeneticsasummaryoftheinfrafrontierforwardgeneticspaneldiscussion AT deangelismartinhrabe movingforwardwithforwardgeneticsasummaryoftheinfrafrontierforwardgeneticspaneldiscussion |